Cargando…
Innovation and competition in advanced therapy medicinal products
Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text...
Autores principales: | Seoane‐Vazquez, Enrique, Shukla, Vaishali, Rodriguez‐Monguio, Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404110/ https://www.ncbi.nlm.nih.gov/pubmed/30770338 http://dx.doi.org/10.15252/emmm.201809992 |
Ejemplares similares
-
Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals
por: Hao, Jing, et al.
Publicado: (2015) -
Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
por: Balkhi, Bander, et al.
Publicado: (2018) -
Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes
por: Kwon, Christina S., et al.
Publicado: (2018) -
Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece?
por: Rodriguez-Monguio, Rosa, et al.
Publicado: (2021) -
A Comparative Assessment of Approvals and Discontinuations of Systemic Antibiotics and Other Therapeutic Areas
por: Rodriguez-Monguio, Rosa, et al.
Publicado: (2023)